NABP vs. URAC Specialty Pharmacy Accreditation — Which Do You Need?
Cost statements revised October 2026.
Which accreditation a specialty pharmacy needs depends on the PBM and health plan contracts it wants to hold. A pharmacy with several PBM contracts should check what each contract asks for, since some pharmacies need more than one accreditation.
This page draws on both programs' published standards and IHS's consulting experience across both bodies.
The One-Paragraph Answer
NABP and URAC are built on different philosophies. NABP functions as a regulatory enforcement and verification body — its accreditation confirms legal compliance, drug supply chain security, and dispensing accuracy. URAC is a quality improvement organization — its accreditation confirms clinical quality management, patient outcome measurement, and care coordination. If a PBM contract you depend on names NABP, read what it asks for before you choose. IHS is an accreditation consulting firm that works with both programs. Thomas G. Goddard, JD, PhD, former URAC COO and General Counsel, personally leads IHS's NABP and URAC engagements.
Side-by-Side Comparison
| Criteria | NABP Specialty Pharmacy Accreditation | URAC Specialty Pharmacy Accreditation |
|---|---|---|
| Accrediting Body | National Association of Boards of Pharmacy (NABP) | URAC (formerly Utilization Review Accreditation Commission) |
| Primary Philosophy | Regulatory enforcement and verification — legal compliance, drug supply chain security, dispensing accuracy | Clinical quality improvement — patient outcomes, care coordination, measurable quality metrics |
| Standards Scope | Section ACC (Accreditation Standards) and Section PHY (Pharmacy Standards) | Specialty Pharmacy core standards plus applicable module standards; multi-year revision cycles with stakeholder comment periods |
| Accreditation Term | 3 years with annual compliance reviews in years 2 and 3 | 3 years with periodic on-site and desk reviews |
| NABP Fees (Specialty Pharmacy) | Published by NABP: estimated three-year totals of $16,750 (low volume), $20,750 (medium) or $25,750 (high) by specialty prescription volume; survey and annual fees are listed per location; verify current fees with NABP. | N/A |
| URAC Fees | N/A | Application and survey fees vary by organization size; contact URAC directly for current schedule |
| IHS Consulting Cost Range | Scoped per engagement — contact for proposal | Scoped per engagement — contact for proposal |
| Typical Timeline | 6–9 months from engagement to award | 6–12 months from engagement to award depending on standards maturity |
| Patient Management Focus | Process completeness: complete profiles, DUR documentation, written education records, welcome kit tracking (PHY.F) | Clinical outcomes: disease-specific outcome measures, patient satisfaction, prescriber care coordination, quality improvement programs |
| Drug Supply Chain Standards | Strong — DSCSA compliance, source verification, controlled substance security, temperature monitoring (ACC.F) | Addressed but not the primary emphasis; supply chain requirements less granular than NABP |
| Personnel Requirements | Pre-hire vetting, initial training documentation, ongoing competency evaluations at required frequencies (ACC.D) | Staff qualifications, ongoing training, competency assessment, clinical staff credentialing |
| Quality Improvement Program | Policies and procedures must address quality improvement; less prescriptive on outcome measurement methodology | Formal quality management program required with outcome metrics, benchmarking, and documented improvement cycles |
| On-Site Survey Format | Announced facility survey; confirm the format with NABP | Announced on-site survey; format varies by accreditation module and organization size |
| State Recognition | Check each state board of pharmacy for what it requires | Check each state and health plan for what it recognizes |
| PBM Network Requirement | Named in some PBM network contracts; check each contract | Named in some PBM and health plan contracts; check each contract |
| Digital Advertising / Payments | NABP Healthcare Merchant Accreditation (separate program; see NABP) | Not applicable |
| Wholesale Distribution | NABP DDA program covers wholesale distributors, 3PLs, 503B facilities, reverse distributors | Not applicable to wholesale drug distribution |
| Current Holders (US) | Holder count not stated here; see NABP for the current number | Holder count not stated here; see URAC for the current number |
| Dual Accreditation | A pharmacy can hold both. IHS structures dual-accreditation engagements using shared documentation to minimize redundant work. | |
Sources: NABP 2026
When to Choose NABP Specialty Pharmacy Accreditation
NABP is the right first choice when your business objective is tied to regulatory compliance or specific PBM network contracts that name NABP explicitly.
Choose NABP When:
- A PBM contract you want names NABP. Read the contract for the accreditation it names.
Wholesale distributors, 3PLs, 503B outsourcing facilities and online pharmacies face a different NABP decision: Drug Distributor Accreditation or Digital Pharmacy Accreditation. Those programs are separate from Specialty Pharmacy Accreditation.
When to Choose URAC Specialty Pharmacy Accreditation
URAC is the right first choice when a health plan or other contract you depend on names URAC, or when you want a clinical quality framework built around patient outcome measurement.
Choose URAC When:
- A health plan contract you depend on names URAC. Read the contract for the accreditation it names.
- Clinical differentiation is your competitive strategy. In markets where multiple accredited pharmacies compete for the same patients, URAC's clinical quality framework provides a more meaningful basis for differentiation than regulatory compliance verification.
IHS is a specialized healthcare accreditation consulting firm founded in 2002 by Thomas G. Goddard, JD, PhD, former URAC COO and General Counsel. See our URAC Specialty Pharmacy Accreditation consulting page for the full URAC service overview.
Can You Get Both? Dual NABP and URAC Accreditation
Yes. A pharmacy can hold both, and one with several PBM contracts and health plan relationships should check what each contract asks for before deciding whether it needs one accreditation or two.
Why Dual Accreditation Works
NABP and URAC standards overlap meaningfully in several operational domains: personnel qualification and training requirements, SOP framework requirements, facility and safety standards, patient management process documentation, and DUR system requirements. A pharmacy that has documented its operations to NABP's standard has already satisfied many of URAC's operational requirements. The incremental burden of adding URAC after NABP — or vice versa — is significantly lower than the sum of two independent accreditation processes.
How IHS Structures Dual-Accreditation Engagements
IHS maps both NABP and URAC standards against your operations in the initial gap analysis, identifying which documentation serves both programs and which requires program-specific development. We sequence surveys to minimize the period during which your staff is managing two simultaneous accreditation timelines. The result: dual accreditation for a total consulting investment that is materially less than two separate engagements billed at full rate.
IHS is a specialized consulting firm with simultaneous active expertise in NABP programs. That cross-program knowledge is not available at firms that specialize in one body.
Market Context: Why Accreditation Matters More Now
The specialty pharmacy accreditation landscape is growing in urgency for two reasons:
- State mandate expansion. State requirements can add to accreditation; check each state board of pharmacy where you ship or distribute. North Carolina HB 163 (2025) passed the House on April 29, 2025 and was referred to the Senate Committee on Rules and Operations on April 30, 2025; it is not law (NC General Assembly bill page). The House-passed version would bar a pharmacy benefits manager from requiring multiple specialty pharmacy accreditations as a prerequisite for participation in a retail pharmacy network that dispenses specialty drugs. It says the accreditation may be issued by URAC, ACHC, the Joint Commission, "their successors, or any similar nationally recognized accrediting organization." It does not name NABP. Source: NC General Assembly, HB 163 House-passed text (H163v3)
- PBM network consolidation. Whether accreditation is required for network participation is set in each PBM's contract; read the contract.
Frequently Asked Questions
Is NABP or URAC better for specialty pharmacy accreditation?
Neither is universally better — they serve different purposes and satisfy different PBM network requirements. A pharmacy with several PBM contracts should check whether any of them asks for more than one accreditation. IHS advises on the right sequencing based on your specific contract portfolio and market objectives — not on which program we find easier to consult.
What is the main philosophical difference between NABP and URAC?
NABP operates as a regulatory enforcement and verification body — its accreditation confirms legal compliance, supply chain security, and operational accuracy. URAC is a quality improvement organization — its accreditation confirms clinical quality management and measurable patient outcomes. NABP answers "Is this pharmacy operating legally and safely?" URAC answers "Is this pharmacy delivering high-quality clinical care?" Sources: PharmaTimes; Pharmacy Times
Can a specialty pharmacy hold both NABP and URAC accreditation?
Yes. A pharmacy can hold both. Dual accreditation can make sense for a pharmacy whose PBM and health plan contracts name both programs. IHS structures dual-accreditation engagements to use shared documentation and staggered survey timelines to minimize total burden.
Which PBMs require NABP vs. URAC?
PBM network requirements vary by contract tier and must be verified against your specific PBM agreements. IHS reviews your contracts as part of every accreditation strategy engagement. Source: NABP blog
How do NABP and URAC accreditation costs compare?
NABP's Specialty Pharmacy pricing page lists an estimated three-year total of $16,750 for a low-volume specialty pharmacy (under 20,000 specialty prescriptions a year), $20,750 for medium volume (20,000 to 99,999) and $25,750 for high volume (100,000 or more); the survey fee and the annual participation fee are listed per location, and NABP does not say how many locations the totals assume. NABP says program fees are subject to change and that additional fees can apply, for example a repeat survey if a pharmacy does not pass. Published by NABP; verify current fees with NABP. URAC specialty pharmacy fees vary by organization size — contact URAC directly for current pricing. IHS consulting fees for either program are scoped per engagement — contact us for a tailored proposal. Dual-accreditation engagements with IHS are more cost-efficient than two separate full-rate engagements because shared documentation work is not duplicated.
Which accreditation should a specialty pharmacy pursue first?
The answer depends on your PBM contract priorities. If a PBM contract names NABP accreditation as a condition of network access, that contract language determines which accreditation to pursue first. If your goal is health plan credentialing, the plan's own credentialing or delegation requirements determine which accreditation it accepts. If both are equally important, IHS structures dual-accreditation engagements that build documentation toward both programs concurrently, with staggered survey timelines to minimize burden.
How do NABP and URAC differ in patient management standards?
NABP's patient management standards (PHY.F) focus on operational completeness: complete patient profiles with diagnosis codes and medication histories, documented DUR cross-referencing, written patient education records, and welcome kit tracking. URAC's patient management standards require clinical depth: disease-specific outcome measures, patient satisfaction tracking, care coordination documentation with prescribers, and quality improvement programs based on outcome data. NABP verifies that patient management processes are in place. URAC verifies that those processes produce measurable clinical results.
Not Sure Which You Need? Schedule a Consultation.
IHS is an accreditation consulting firm directed by Thomas G. Goddard, JD, PhD (former URAC COO and General Counsel). We start every engagement by reviewing your PBM contracts, state distribution footprint, and organizational profile to identify the right accreditation path before you invest in the process.
Cost statements revised October 2026.
